Smart Biologics: AI-Driven mRNA Vaccine Design & Computational Precision Medicine 2027(Smart Biologics2027)
20–21 October 2027 | Zurich, Switzerland
Theme:
“Engineering the Future of Biologics: AI, mRNA Innovation & Computational Precision Medicine for Next-Generation Healthcare”
All registered participants of Scientific Research Conferences 2027 will receive a Certificate of Attendance accredited with 10 CPD Credits.
Smart Biologics 2027 brings together researchers, physicians, vaccinologists, immunologists, molecular biologists, computational scientists, bioinformaticians, pharmaceutical scientists, biotechnology experts, academicians, healthcare professionals, and industry leaders to explore the convergence of artificial intelligence, mRNA technology, vaccine development, biologics, and computational precision medicine.
The conference will provide an international platform for exchanging knowledge on AI-enabled vaccine discovery, computational biology, mRNA design and optimization, personalized medicine, advanced biologics, and next-generation therapeutic technologies.
The conference will be conducted in a hybrid format, allowing participants to attend physically in Switzerland or participate virtually from anywhere in the world.
Important Dates
- Abstract Submission Deadline: August 31, 2027
- Mid Term Registration Deadline: September 10, 2027
- Conference Dates: 20–21 October 2027
About the Conference
The rapid convergence of artificial intelligence, computational biology, genomics, and biotechnology is transforming the development of vaccines and biologic therapeutics. Smart Biologics 2027 focuses on emerging technologies that are accelerating the discovery, design, optimization, manufacturing, and clinical translation of next-generation biologics.
A major focus of the conference will be AI-driven mRNA vaccine design, including computational sequence optimization, antigen prediction, structural modeling, immune-response prediction, delivery technologies, and vaccine safety and efficacy.
The conference will also examine the role of computational precision medicine in integrating genomic, transcriptomic, proteomic, clinical, and other biological data to support individualized prevention, diagnosis, and treatment.
Participants will have opportunities to discuss emerging developments in mRNA vaccines, RNA therapeutics, biologics, computational drug discovery, AI/ML applications, bioinformatics, immunoinformatics, systems biology, personalized medicine, and advanced biotechnology platforms.
Conference Topics
- Artificial Intelligence in Biologics
- AI-Driven Vaccine Design
- Machine Learning for Vaccine Development
- Generative AI in Drug and Vaccine Discovery
- mRNA Vaccine Technology
- mRNA Sequence Design and Optimization
- mRNA Stability and Translation
- mRNA Vaccine Formulation
- mRNA Delivery Systems
- Lipid Nanoparticles and RNA Delivery
- Next-Generation Vaccine Platforms
- Computational Vaccine Design
- Reverse Vaccinology and Immunoinformatics
- Antigen and Epitope Prediction
- Computational Immunology
- Structural Bioinformatics
- Molecular Modeling and Simulation
- Protein Structure Prediction
- AI-Based Protein Engineering
- Computational Biology
- Bioinformatics and Multi-Omics
- Genomics and Transcriptomics
- Proteomics and Systems Biology
- Computational Precision Medicine
- Personalized and Precision Healthcare
- Pharmacogenomics
- Biomarkers and Predictive Analytics
- AI in Clinical Decision Support
- Digital Health and Precision Medicine
- RNA-Based Therapeutics
- Gene Therapy and Advanced Therapies
- Monoclonal Antibodies and Therapeutic Proteins
- Biosimilars and Biologic Medicines
- Immunotherapy and Cancer Vaccines
- Infectious Disease Vaccines
- Personalized Vaccination Strategies
- Vaccine Safety and Efficacy
- Clinical Translation of mRNA Technologies
- AI in Clinical Trials
- Regulatory Science for AI and Biologics
- Biomanufacturing and Process Optimization
- Quality Control of Biologics
- Ethical and Responsible AI in Healthcare
- Future Directions in Smart Biologics
Why Attend?
Present Your Research
Share innovative research in AI, mRNA technology, computational biology, vaccine development, biologics, and precision medicine.
Learn from Experts
Gain insights into emerging technologies and scientific breakthroughs from researchers, clinicians, biotechnology experts, and industry leaders.
Network Globally
Connect with international experts across artificial intelligence, biotechnology, pharmaceutical sciences, immunology, genomics, and healthcare.
Explore Emerging Technologies
Discover how AI and computational approaches are accelerating vaccine design, biologic development, and personalized healthcare.
Build Collaborations
Identify opportunities for international research partnerships, biotechnology collaborations, clinical research, and technology development.
Publication Opportunities
Selected contributions may be considered for publication in relevant journals or special issues, subject to editorial and peer-review requirements.
Benefits of Attending
- Present research to an international scientific audience
- Participate in expert scientific discussions
- Attend keynote and invited presentations
- Network with researchers and biotechnology professionals
- Explore AI-driven vaccine and biologics technologies
- Learn about emerging mRNA platforms and delivery systems
- Discover advances in computational precision medicine
- Develop international research collaborations
- Interact with pharmaceutical and biotechnology industries
- Certificate of Participation with 10 CPD Credits
- Abstract publication opportunities
- Explore emerging AI and computational healthcare technologies
- Opportunities for institutional and industry collaboration
- Opportunities for sponsorship and technology showcasing
Call for Papers
Smart Biologics 2027 welcomes submissions from researchers, scientists, clinicians, academicians, biotechnology professionals, pharmaceutical scientists, computational scientists, students, and industry experts.
We invite submissions in the form of:
- Full Research Papers
- Short Research Papers
- Work-in-Progress Papers
- Poster Presentations
- Case Studies
- Clinical Research Presentations
- Computational and Bioinformatics Studies
- AI/ML Research Presentations
- Vaccine Development Studies
- mRNA Technology Research
- Biologics and Therapeutics Research
- Industrial Research Presentations
- Technology and Innovation Presentations
Indexing & Publication
Conference proceedings will be evaluated for inclusion in relevant major indexing and abstracting services, subject to their respective evaluation and acceptance criteria.
Selected high-quality contributions may also be considered for publication in relevant peer-reviewed journals or special issues, subject to editorial policies, peer review, and journal acceptance.
Honorarium for Keynote & Invited Speakers
Keynote and invited speakers may be eligible for an honorarium upon meeting the conference participation requirements, including securing a minimum of 5 paid registrations.
The honorarium amount may vary depending on the number of confirmed paid registrations.
Travel & Accommodation
Smart Biologics 2027 does not provide travel sponsorship or reimbursement for speakers or participants.
Participants are responsible for arranging and covering their own:
- International/domestic travel
- Accommodation
- Visa expenses
- Local transportation
- Personal expenses
Important Note
Smart Biologics 2027 is an independently organized scientific conference. Registration fees support conference planning, venue and technical arrangements, scientific program management, participant services, publication-related activities, and other operational requirements.
Participation is available through both in-person and virtual formats, providing flexibility for researchers, clinicians, academicians, and industry professionals worldwide.
Venue
Switzerland
The specific conference venue will be announced/confirmed as part of the official conference arrangements.
Contact Us
For inquiries regarding abstract submission, speaker participation, registration, sponsorship, and collaboration opportunities:
Email: smartbiologics@srcconferences.net
LinkedIn: https://www.linkedin.com/in/pinnika-bhargav-44a394386/
Register Now
Join Smart Biologics 2027 in Switzerland on 20–21 October 2027 and become part of an international scientific platform exploring the convergence of AI, mRNA vaccine technology, computational biology, biologics, and precision medicine.
Submit your research. Share your expertise. Connect with global innovators. Engineer the future of smart biologics.
Scientific Program
Smart Biologics: AI-Driven mRNA Vaccine Design & Computational Precision Medicine 2027
20–21 October 2027 | Switzerland
Hybrid Conference – In-Person & Virtual
Conference Theme
“Engineering the Future of Biologics: AI, mRNA Innovation & Computational Precision Medicine for Next-Generation Healthcare”
Day 1 – AI, mRNA & Computational Vaccine Innovation
08:30 – 09:00
Registration & Welcome Coffee
09:00 – 09:15
Opening Ceremony & Welcome Address
09:15 – 10:00
Keynote Session
Artificial Intelligence and the Future of Smart Biologics
Exploring how AI and machine learning are transforming biologics discovery, vaccine development, computational biology, and therapeutic innovation.
10:00 – 11:00
Session 1
Artificial Intelligence in Biologics & Drug Discovery
Topics include generative AI, machine learning, molecular discovery, target identification, predictive modeling, and AI-assisted therapeutic development.
11:00 – 11:20
Coffee & Networking Break
11:20 – 12:20
Session 2
AI-Driven mRNA Vaccine Design & Optimization
Focus on computational sequence design, antigen prediction, codon optimization, mRNA stability, translation efficiency, and AI-assisted vaccine development.
12:20 – 13:20
Session 3
mRNA Vaccine Technology, Delivery & Formulation
Exploring lipid nanoparticles, RNA delivery systems, formulation technologies, cellular uptake, stability, scalability, and next-generation mRNA platforms.
13:20 – 14:20
Lunch & Networking
14:20 – 15:20
Session 4
Computational Vaccine Design & Immunoinformatics
Reverse vaccinology, antigen and epitope prediction, immunoinformatics, computational immunology, pathogen modeling, and immune-response prediction.
15:20 – 16:20
Session 5
Structural Bioinformatics, Protein Engineering & Molecular Modeling
Protein structure prediction, molecular dynamics, structural bioinformatics, computational protein design, AI-based protein engineering, and structure-guided biologics development.
16:20 – 16:40
Coffee & Networking Break
16:40 – 17:40
Session 6
Computational Biology, Bioinformatics & Multi-Omics
Genomics, transcriptomics, proteomics, systems biology, multi-omics integration, biological data analysis, and machine learning applications.
17:40 – 18:20
Session 13
AI-Powered Biomarker Discovery & Therapeutic Target Identification
AI-based biomarker discovery, target validation, disease pathway analysis, predictive biomarkers, and computational approaches to personalized therapeutic development.
18:20 – 18:40
Day 1 Panel Discussion
From AI Models to Biological Impact: Challenges in Translating Computational Discoveries
18:40
End of Day 1
Day 2 – Precision Medicine, Therapeutics & Future Biologics
09:00 – 09:15
Day 2 Welcome & Recap
09:15 – 10:00
Keynote Session
Computational Precision Medicine: From Multi-Omics to Personalized Healthcare
Exploring how genomic, transcriptomic, proteomic, clinical, and computational data can support individualized prevention, diagnosis, and treatment.
10:00 – 11:00
Session 7
Computational Precision Medicine & Personalized Healthcare
Genomic medicine, pharmacogenomics, biomarker discovery, patient stratification, predictive analytics, and AI-enabled clinical decision support.
11:00 – 11:20
Coffee & Networking Break
11:20 – 12:20
Session 8
RNA Therapeutics, Gene Therapy & Advanced Biologics
RNA therapeutics, gene therapy, gene editing, therapeutic proteins, monoclonal antibodies, biosimilars, and emerging advanced therapeutic platforms.
12:20 – 13:20
Session 9
Cancer Vaccines, Immunotherapy & Infectious Disease Vaccines
Personalized cancer vaccines, mRNA cancer vaccines, immunotherapy, infectious disease vaccines, emerging pathogens, and AI-assisted immunotherapeutic research.
13:20 – 14:20
Lunch & Networking
14:20 – 15:10
Session 14
Digital Twins, Virtual Screening & Predictive Biomedicine
Digital twins, virtual screening, in silico drug discovery, computational disease modeling, predictive pharmacology, and simulation-based biomedical research.
15:10 – 16:00
Session 15
Next-Generation Vaccine Platforms & Global Vaccine Innovation
Self-amplifying RNA, next-generation mRNA platforms, nanoparticle vaccines, universal vaccine strategies, rapid-response technologies, and pandemic preparedness.
16:00 – 16:20
Coffee & Networking Break
16:20 – 17:20
Session 10
Clinical Translation, AI in Clinical Trials & Regulatory Science
Clinical translation of mRNA and biologics technologies, AI in clinical trials, patient selection, biomarkers, safety, efficacy, and regulatory considerations.
17:20 – 18:00
Session 11
Biomanufacturing, Quality Control & Process Optimization
Biologics manufacturing, mRNA manufacturing, process development, scale-up, AI-based process optimization, analytical technologies, and quality control.
18:00 – 18:40
Session 16
Translational Biotechnology, Industry Innovation & Commercialization
Technology transfer, biotech innovation, industry–academia collaboration, intellectual property, commercialization, product development, and investment opportunities.
18:40 – 19:20
Session 12
Future of Smart Biologics, Responsible AI & Emerging Technologies
Responsible AI, ethics, data governance, emerging biotechnology, interdisciplinary collaboration, and the future convergence of AI, mRNA, biologics, and precision medicine.
19:20 – 19:45
Closing Panel
Engineering the Future of Smart Biologics
A multidisciplinary discussion on the next generation of AI-enabled vaccines, biologics, computational medicine, and personalized healthcare.
19:45 – 20:00
Closing Remarks & Certificate Presentation
Special Program Features
Keynote Presentations
International experts will present high-impact perspectives on AI, mRNA technology, biologics, computational biology, and precision medicine.
Invited Speaker Sessions
Leading researchers and industry professionals will share recent developments, technologies, and applications.
Oral Presentations
Researchers are invited to present original research, clinical studies, computational studies, and emerging technological innovations.
Poster Presentations
Poster sessions will provide opportunities for researchers and early-career scientists to showcase their work and interact with international participants.
Industry & Innovation Forum
A dedicated platform for biotechnology, pharmaceutical, AI, and technology companies to present emerging products, platforms, and innovations.
Interactive Panel Discussions
Experts from academia, healthcare, biotechnology, pharmaceutical sciences, and technology will discuss challenges, opportunities, and future directions.
Networking & Collaboration
Participants will have opportunities to establish international research collaborations, industry partnerships, and academic connections.
Program timings and presentation order are subject to change based on speaker confirmations and final scientific program arrangements.
Conference sessions
Browse the current session list for Smart Biologics: AI-Driven mRNA Vaccine Design & Computational Precision Medicine.
Translational Biotechnology, Industry Innovation & Commercialization
This session brings together academic researchers, biotechnology companies, pharmaceutical organizations, and technology innovators to discuss the translation of scientific discoveries into practical products and therapies. Topics will include technology transfer, biotech startups, industry–academia collaboration, intellectual property, commercialization strategies, product development, investment opportunities, and the future of AI-enabled biotechnology.
Next-Generation Vaccine Platforms & Global Vaccine Innovation
This session focuses on emerging vaccine technologies designed to improve speed, scalability, adaptability, and global accessibility. Presentations will explore self-amplifying RNA vaccines, next-generation mRNA platforms, nanoparticle-based vaccines, universal vaccine strategies, rapid-response vaccine development, pandemic preparedness, and innovative approaches to global immunization.
Digital Twins, Virtual Screening & Predictive Biomedicine
This session examines emerging computational technologies that enable virtual experimentation and predictive modeling in biomedical research. Topics will include digital twins, virtual screening, in silico drug discovery, computational disease modeling, predictive pharmacology, AI-generated biological models, and simulation-based approaches for accelerating therapeutic development.
AI-Powered Biomarker Discovery & Therapeutic Target Identification
This session explores the use of artificial intelligence and computational approaches to identify novel disease biomarkers and therapeutic targets. Discussions will cover biomarker discovery, target validation, machine learning models, biological data mining, disease pathway analysis, patient stratification, and the development of predictive biomarkers for personalized therapies.
Future of Smart Biologics, Responsible AI & Emerging Technologies
This forward-looking session explores the future convergence of artificial intelligence, biotechnology, mRNA technologies, computational medicine, and advanced biologics. Discussions will address responsible AI, ethical considerations, data governance, emerging technologies, interdisciplinary collaboration, commercialization, and the next generation of intelligent and personalized healthcare solutions.
Biomanufacturing, Quality Control & Process Optimization
This session examines emerging technologies for the manufacturing and quality control of biologics, vaccines, and mRNA products. Topics include process development, scale-up, continuous manufacturing, AI-based process optimization, analytical technologies, quality control, formulation consistency, and strategies for improving the efficiency and reliability of biopharmaceutical production.
Clinical Translation, AI in Clinical Trials & Regulatory Science
This session addresses the translation of computationally designed biologics and mRNA technologies from research laboratories into clinical applications. Discussions will cover AI in clinical trials, patient selection, biomarkers, clinical development, safety and efficacy assessment, regulatory considerations, data standards, and the evolving regulatory landscape for AI-enabled biologics.
Cancer Vaccines, Immunotherapy & Infectious Disease Vaccines
This session focuses on innovative vaccine and immunotherapeutic strategies for cancer and infectious diseases. Topics will include personalized cancer vaccines, mRNA cancer vaccines, tumor antigens, immune modulation, infectious disease vaccine development, emerging pathogens, personalized vaccination strategies, and AI-assisted immunotherapy research.
RNA Therapeutics, Gene Therapy & Advanced Biologics
This session explores the expanding landscape of RNA-based therapeutics, gene therapies, and advanced biologic medicines. Topics will include mRNA therapeutics beyond vaccines, RNA delivery, gene editing, therapeutic proteins, monoclonal antibodies, biosimilars, and emerging platforms designed to address complex diseases.
Computational Precision Medicine & Personalized Healthcare
This session examines how computational technologies are enabling more personalized approaches to healthcare. Discussions will focus on genomic medicine, pharmacogenomics, biomarker discovery, patient stratification, predictive analytics, individualized treatment strategies, and AI-enabled clinical decision support.
Computational Biology, Bioinformatics & Multi-Omics
This session focuses on the integration of computational biology, bioinformatics, and multi-omics technologies to understand complex biological systems. Topics will include genomics, transcriptomics, proteomics, systems biology, biological data integration, machine learning for biological datasets, and computational approaches for discovering new therapeutic insights.
Structural Bioinformatics, Protein Engineering & Molecular Modeling
This session explores computational approaches for understanding and engineering biological molecules. Presentations will address protein structure prediction, molecular modeling, molecular dynamics, structural bioinformatics, AI-based protein engineering, computational protein design, and structure-guided development of biologics and therapeutic candidates.
Computational Vaccine Design & Immunoinformatics
This session highlights computational approaches for modern vaccine discovery and development. Topics include reverse vaccinology, antigen and epitope prediction, immunoinformatics, computational immunology, pathogen modeling, immune-response prediction, and AI-enabled identification of promising vaccine targets.
mRNA Vaccine Technology, Delivery & Formulation
This session examines advances in mRNA vaccine platforms, formulation technologies, and delivery systems. Particular emphasis will be placed on lipid nanoparticles, RNA stability, targeted delivery, cellular uptake, formulation optimization, scalable manufacturing, and emerging approaches for improving the safety, efficacy, and durability of mRNA-based vaccines.
AI-Driven mRNA Vaccine Design & Optimization
This session focuses on the application of artificial intelligence and computational methods to the design and optimization of mRNA vaccines. Discussions will cover sequence optimization, antigen selection, codon optimization, mRNA stability, translation efficiency, immune-response prediction, and AI-assisted vaccine candidate development.
Artificial Intelligence in Biologics & Drug Discovery
This session explores the transformative role of artificial intelligence and machine learning in the discovery, design, and development of biologics and therapeutic candidates. Topics will include AI-powered molecular discovery, predictive modeling, generative AI, target identification, lead optimization, and computational approaches that accelerate biopharmaceutical research and development.
Submit your abstract
Mail your abstract to contact@srcmeetings.com or submit it online using the form below.
Registration details
Registration windows, pricing categories, and key dates for this conference.
Select the active registration option to continue with attendee details here.
Featured speakers
Speaker profiles will be published soon.
Organizing committee members
contact@srcmeetings.com
Zurich, Switzerland
Nearby attractions will be added soon.
Smart Biologics: AI-Driven mRNA Vaccine Design & Computational Precision Medicine
contact@srcmeetings.com
For registration, abstract submission, speaker participation, or venue coordination, email our support team or submit your query through the online contact form.